Artificial Intelligence in Coronavirus Drug and Vaccine Development - Part 2
In Part 1 of the article on AI in COVID Drug and Vaccine development, we discussed about how AI is used extensively in any drug and vaccine development. In this part, we will look deeper into how AI is specifically being used in COVID-19 drug and vaccine development. The recent applications of Artificial Intelligence for COVID-19 include the virtual screening of both repurposed drug candidates and new chemical entities. For repurposed drugs, the goal has been to rapidly predict and exploit interconnected biological pathways or the off-target biology of existing medicines that are proven safe and can thus be readily tested in new clinical trials. Scientists leveraged AI-derived knowledge graph, which integrates biomedical data from structured and unstructured sources. Similarly, other scientists published an application of their Deep Learning-based drug–target interaction model that predicted commercially available antiviral drugs that may target the COVID-19-related protease and hel